These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11078296)

  • 1. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators.
    de Lemos JA; Antman EM; Giugliano RP; McCabe CH; Murphy SA; Van de Werf F; Gibson CM; Braunwald E
    Am J Cardiol; 2000 Feb; 85(3):299-304. PubMed ID: 11078296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.
    de Lemos JA; Gibson CM; Antman EM; Murphy SA; Morrow DA; Schuhwerk KC; Schweiger M; Coussement P; Van de Werf F; Braunwald E;
    Am Heart J; 2001 Apr; 141(4):592-8. PubMed ID: 11275925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of infarct-related coronary artery patency and microcirculatory function after facilitated percutaneous primary coronary angioplasty: the FINESSE-ANGIO (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events-Angiographic) study.
    Prati F; Petronio S; Van Boven AJ; Tendera M; De Luca L; de Belder MA; Galassi AR; Imola F; Montalescot G; Peruga JZ; Barnathan ES; Ellis S; Savonitto S;
    JACC Cardiovasc Interv; 2010 Dec; 3(12):1284-91. PubMed ID: 21232723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
    Rakowski T; Siudak Z; Dziewierz A; Birkemeyer R; Janzon M; Mielecki W; Zmudka K; Dubiel JS; Dudek D
    Kardiol Pol; 2012; 70(3):215-21. PubMed ID: 22430397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials).
    Brener SJ; Mehran R; Brodie BR; Guagliumi G; Witzenbichler B; Cristea E; Xu K; Lansky AJ; Stone GW
    Am J Cardiol; 2011 Oct; 108(7):918-23. PubMed ID: 21764028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial.
    Murphy SA; Dauterman K; de Lemos JA; Kermgard S; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2003 Jul; 146(1):42-7. PubMed ID: 12851606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.
    Antman EM; Giugliano RP; Gibson CM; McCabe CH; Coussement P; Kleiman NS; Vahanian A; Adgey AA; Menown I; Rupprecht HJ; Van der Wieken R; Ducas J; Scherer J; Anderson K; Van de Werf F; Braunwald E
    Circulation; 1999 Jun; 99(21):2720-32. PubMed ID: 10351964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Infarct-Related Artery Patency Before Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (from the FAST-MI 2010 Registry).
    Bailleul C; Puymirat E; Aissaoui N; Schiele F; Ducrocq G; Coste P; Blanchard D; Brasselet C; Elbaz M; Steg PG; Le Breton H; Bonnefoy-Cudraz E; Montalescot G; Cottin Y; Goldstein P; Ferrières J; Simon T; Danchin N;
    Am J Cardiol; 2016 Jan; 117(1):17-21. PubMed ID: 26541905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration.
    Cooper HA; de Lemos JA; Morrow DA; Sabatine MS; Murphy SA; McCabe CH; Gibson CM; Antman EM; Braunwald E
    Am Heart J; 2002 Nov; 144(5):790-5. PubMed ID: 12422146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST-Segment resolution as a marker of epicardial and myocardial reperfusion after thrombolysis: insights from the TIMI 14 and in TIME-II trials.
    de Lemos JA
    J Electrocardiol; 2000; 33 Suppl():67-72. PubMed ID: 11265739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy.
    Gibson CM; de Lemos JA; Murphy SA; Marble SJ; McCabe CH; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2001 May; 103(21):2550-4. PubMed ID: 11382722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-Procedural Thrombolysis in Myocardial Infarction Flow in Patients with ST-Segment Elevation Myocardial Infarction.
    Hashimoto T; Ako J; Nakao K; Ozaki Y; Kimura K; Noguchi T; Yasuda S; Suwa S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Uematsu M; Hirata K; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Toubaru T; Saku K; Oshima S; Nakai M; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
    Int Heart J; 2018 Sep; 59(5):920-925. PubMed ID: 30158385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of infarct-related artery patency following combined lytic therapy in patients with ST-segment elevation myocardial infarction treated with immediate percutaneous coronary intervention.
    Rakowski T; Dziewierz A; Siudak Z; Mielecki W; Bierca K; Legutko J; Dubiel JS; Dudek D
    Kardiol Pol; 2011; 69(5):452-7. PubMed ID: 21594830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
    Cura FA; Roffi M; Pasca N; Wolski KE; Lincoff AM; Topol EJ; Lauer MS;
    Am J Cardiol; 2004 Oct; 94(7):859-63. PubMed ID: 15464665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial.
    Zeymer U; Schröder R; Tebbe U; Molhoek GP; Wegscheider K; Neuhaus KL
    Eur Heart J; 2001 May; 22(9):769-75. PubMed ID: 11350109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.
    Rakowski T; Dudek D; Dziewierz A; Yu J; Witzenbichler B; Guagliumi G; Kornowski R; Hartmann F; Lansky AJ; Brener SJ; Mehran R; Stone GW
    EuroIntervention; 2013 Mar; 8(11):1307-14. PubMed ID: 23538158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of baseline coronary occlusion and diabetes mellitus in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Piccolo R; Galasso G; Iversen AZ; Eitel I; Dominguez-Rodriguez A; Gu YL; de Smet BJ; Mahmoud KD; Abreu-Gonzalez P; Trimarco B; Thiele H; Piscione F
    Am J Cardiol; 2014 Oct; 114(8):1145-50. PubMed ID: 25193670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment.
    Shah A; Wagner GS; Granger CB; O'Connor CM; Green CL; Trollinger KM; Califf RM; Krucoff MW
    J Am Coll Cardiol; 2000 Mar; 35(3):666-72. PubMed ID: 10716469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial.
    Svensson L; Aasa M; Dellborg M; Gibson CM; Kirtane A; Herlitz J; Ohlsson A; Karlsson T; Grip L
    Am Heart J; 2006 Apr; 151(4):798.e1-7. PubMed ID: 16569536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R
    JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.